Articles Tagged With:
-
Team-based Pod System Reduces Lengths of Stay for Treat-and-Release Patients
Administrators note an expanded role for clinicians assigned to treat lower-acuity patients and a revamped pediatric area have contributed to improved flow and rising patient satisfaction.
-
Assessing Risk for Future Firearms Violence in Young People Who Present to ED
A new 10-point scale offers potential intervention methods for patients most in need of prevention services.
-
Palliative Care Occupies Growing Presence in ED
Experts note that identifying palliative care options is the first step toward making such services accessible to ED patients.
-
Evaluation and Management of Abscesses in the Emergency Department
This article reviews the current management options for simple cutaneous abscesses in patients, including review of the epidemiology, differential diagnosis, diagnostic studies, and changing practice of wound cultures and antibiotic therapy.
-
Doctors Aim for Better Heart Failure Prevention
Early, noninvasive tests may be key, according to top heart orgs.
-
Is This Fascicular Ventricular Tachycardia?
The ECG in the figure in this story was obtained from a 55-year-old man who presented for emergency care with palpitations and fatigue. His blood pressure was 80/50 mmHg at the time the tracing was recorded. Is this a case of ventricular tachycardia?
-
Clinical Briefs
In this section: treating depression; the subdural risk of antithrombotics; and the health consequences of a poor diet.
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.